TD Cowen analyst Robert Moskow lowered the firm’s price target on Procter & Gamble to $150 from $168 and keeps a Buy rating on the shares. The firm adjusted price targets in consumer staples as part of a 2026 outlook. TD expects a “challenging” year for large-cap consumer staples with volume growth unlikely to improve materially from the negative 0.9% in 2025 and pricing “muted.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble assumed with a Neutral at Piper Sandler
- Procter & Gamble price target lowered to $158 from $170 at Wells Fargo
- Coty announces Markus Strobel as chairman, interim CEO
- Procter & Gamble price target lowered to $170 from $175 at BofA
- Procter & Gamble price target lowered to $157 from $165 at JPMorgan
